Midgard Science

PreviPharma GmbH

Mannheim, Germany previpharma.com From their website, Nov 2026

  • GLP
  • GMP

Work here? Claim this listing

About

PreviPharma GmbH is a research and manufacturing partner for the plasma fractionation industry. It supports projects across the R&D supply chain, from early research and analytical development to GMP-compliant manufacturing and life-cycle management. The company is based in Mannheim, Germany.

Services

  • Research services

    Supports projects across the plasma fractionation R&D value chain, from early-stage research and clinical study guidance through production process support and life-cycle management.

  • Strategic research support

    Provides guidance for target validation, mode of action analysis, and candidate selection, with close integration to in-vivo programs.

  • Process development and optimization

    Develops and optimizes plasma protein processes from source materials through product formation, including chromatographic, filtration, fractionation, and formulation steps.

  • Analytical method development and implementation

    Develops, qualifies, and implements analytical methods, including matrix evaluation, feasibility assessment, method optimization, bridging studies, and preparation for regulatory validation.

  • Preclinical capabilities and expertise

    Provides in-vitro and in-vivo research support, including screening, mechanistic studies, translational research, and regulated preclinical development.

  • Manufacturing of plasma proteins

    Produces research-grade, GLP-tox-compliant, and GMP-compliant plasma protein material, with up- and downscaling and contract manufacturing support.

    CDMO: development & manufacturing

  • End-to-end quality

    Maintains integrated quality systems, SOPs, documentation, traceability, audits, and data-integrity processes across research, development, and manufacturing work.

  • Preclinical & Clinical Capabilities & Expertise

    Offers in-vitro analytics, in-vivo studies, clinical study planning and guidance, and pathogen safety studies.

1 more services
  • Development & Execution of Analytical Methods
What to send
Patient samples and data

Capabilities

Assays and studies
  • Process development
  • Toxicology
  • Cell-based assays
  • Biochemical assays
  • In-vitro analytics
  • In-vivo studies
15 more
  • Clinical studies
  • Pathogen safety studies
  • Diagnostic studies
  • Method development
  • Validation
  • Purity assessment
  • Identity confirmation
  • Impurity quantification
  • Aggregation analysis
  • Stability profiling
  • Fragmentation studies
  • Target validation
  • Mode of Action (MoA) analysis
  • Advanced testing
  • Advanced diagnostics
Scale and capacity
  • Up to 30 liters
  • Up to 100 liters
  • Batch chromatography 1 mL to 10 L column volume
  • Filtration areas from 0.0073 m² to 0.1 m²
  • Filter presses frame width 10–30 cm
  • Up to 300 liters
  • 100 L
  • Future expansion projected up to 2,000 liters
Therapeutic areas
  • Plasma fractionation
  • Plasma protein therapies

Instruments and platforms

  • Nanofiltration (NF)
  • PCC
  • SMB
  • TFF

Modalities and species

Modalities
  • Plasma proteins
  • Plasma-derived proteins
  • Existing proteins
  • Novel proteins
  • Plasma fractionation products

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    As listed: GMP (GMP-compliant production and GMP-proximal production environments); GMP-like (research grade and pilot scale production processes); GMP-like QM system

  • GLPSelf-reported

    Scope: material

Industries served

  • Plasma fractionation industry
  • Pharmaceutical

Details

Type
CRDMO
Based in
Mannheim, Germany
Serves
International
General enquiry
info@previpharma.com on their site
Phone
+49 (0) 621 72 847 848

Similar labs